nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Somnolence—Captopril—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Nitazoxanide—Dyspepsia—Captopril—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Nitazoxanide—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Nitazoxanide—Dizziness—Pentoxifylline—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Nitazoxanide—Hypertension—Leflunomide—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Nitazoxanide—Decreased appetite—Captopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Nitazoxanide—Malaise—Mycophenolic acid—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Nitazoxanide—Infection—Azathioprine—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Nitazoxanide—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Nitazoxanide—Syncope—Mycophenolic acid—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Nitazoxanide—Myalgia—Leflunomide—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Nitazoxanide—Constipation—Captopril—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Nitazoxanide—Flatulence—Lisinopril—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Nitazoxanide—Discomfort—Leflunomide—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Nitazoxanide—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Nitazoxanide—Dry mouth—Leflunomide—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Nitazoxanide—Back pain—Lisinopril—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Nitazoxanide—Vomiting—Pentoxifylline—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Nitazoxanide—Muscle spasms—Lisinopril—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Nitazoxanide—Rash—Pentoxifylline—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Nitazoxanide—Hypertension—Mycophenolic acid—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Nitazoxanide—Dermatitis—Pentoxifylline—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Nitazoxanide—Headache—Pentoxifylline—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Nitazoxanide—Feeling abnormal—Captopril—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Nitazoxanide—Myalgia—Mycophenolic acid—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Nitazoxanide—Infection—Leflunomide—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Captopril—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Nitazoxanide—Asthenia—Mometasone—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Nitazoxanide—Tremor—Lisinopril—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Nitazoxanide—Discomfort—Mycophenolic acid—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Nitazoxanide—Pruritus—Mometasone—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Nitazoxanide—Tachycardia—Leflunomide—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Nitazoxanide—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Nitazoxanide—Anaemia—Lisinopril—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Nitazoxanide—Abdominal pain—Captopril—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Nitazoxanide—Body temperature increased—Captopril—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Nitazoxanide—Oedema—Mycophenolic acid—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Nitazoxanide—Anorexia—Leflunomide—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Nitazoxanide—Nausea—Pentoxifylline—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Nitazoxanide—Chills—Mycophenolate mofetil—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Nitazoxanide—Malaise—Lisinopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Nitazoxanide—Infection—Mycophenolic acid—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Nitazoxanide—Diarrhoea—Mometasone—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Nitazoxanide—Syncope—Lisinopril—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Nitazoxanide—Shock—Mycophenolic acid—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Nitazoxanide—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Nitazoxanide—Loss of consciousness—Lisinopril—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Nitazoxanide—Anorexia—Mycophenolic acid—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Nitazoxanide—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Nitazoxanide—Insomnia—Leflunomide—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Nitazoxanide—Myalgia—Lisinopril—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Nitazoxanide—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Nitazoxanide—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Nitazoxanide—Discomfort—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Nitazoxanide—Dyspepsia—Leflunomide—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Nitazoxanide—Vomiting—Mometasone—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Nitazoxanide—Dry mouth—Lisinopril—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Nitazoxanide—Feeling abnormal—Azathioprine—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Nitazoxanide—Rash—Mometasone—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Nitazoxanide—Asthenia—Captopril—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Nitazoxanide—Dermatitis—Mometasone—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Nitazoxanide—Decreased appetite—Leflunomide—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Nitazoxanide—Headache—Mometasone—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Nitazoxanide—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Nitazoxanide—Insomnia—Mycophenolic acid—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Nitazoxanide—Oedema—Lisinopril—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Nitazoxanide—Pruritus—Captopril—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Nitazoxanide—Constipation—Leflunomide—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Nitazoxanide—Pain—Leflunomide—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Nitazoxanide—Infection—Lisinopril—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Nitazoxanide—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Nitazoxanide—Somnolence—Mycophenolic acid—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Nitazoxanide—Shock—Lisinopril—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Nitazoxanide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Nitazoxanide—Tachycardia—Lisinopril—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Nitazoxanide—Abdominal pain—Azathioprine—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Nitazoxanide—Body temperature increased—Azathioprine—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Nitazoxanide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Nitazoxanide—Diarrhoea—Captopril—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Nitazoxanide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.002	0.002	CcSEcCtD
Nitazoxanide—Syncope—Mycophenolate mofetil—systemic scleroderma	0.002	0.002	CcSEcCtD
Nitazoxanide—Feeling abnormal—Leflunomide—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Nitazoxanide—Nausea—Mometasone—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Nitazoxanide—Anorexia—Lisinopril—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Nitazoxanide—Pain—Mycophenolic acid—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Nitazoxanide—Constipation—Mycophenolic acid—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Nitazoxanide—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Nitazoxanide—Dizziness—Captopril—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Nitazoxanide—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Nitazoxanide—Body temperature increased—Leflunomide—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Nitazoxanide—Abdominal pain—Leflunomide—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Nitazoxanide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Nitazoxanide—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Nitazoxanide—Hypersensitivity—Azathioprine—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Nitazoxanide—Insomnia—Lisinopril—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Nitazoxanide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Nitazoxanide—Vomiting—Captopril—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Nitazoxanide—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Nitazoxanide—Rash—Captopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Nitazoxanide—Dermatitis—Captopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Nitazoxanide—Somnolence—Lisinopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Nitazoxanide—Headache—Captopril—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Nitazoxanide—Dyspepsia—Lisinopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Nitazoxanide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Nitazoxanide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Nitazoxanide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Nitazoxanide—Infection—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Nitazoxanide—Decreased appetite—Lisinopril—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Nitazoxanide—Shock—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Nitazoxanide—Hypersensitivity—Leflunomide—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Nitazoxanide—Constipation—Lisinopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Nitazoxanide—Pain—Lisinopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Nitazoxanide—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Nitazoxanide—Diarrhoea—Azathioprine—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Nitazoxanide—Nausea—Captopril—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Nitazoxanide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Nitazoxanide—Asthenia—Leflunomide—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Nitazoxanide—Feeling abnormal—Lisinopril—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Nitazoxanide—Pruritus—Leflunomide—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Nitazoxanide—Dysuria—Methotrexate—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Nitazoxanide—Dizziness—Azathioprine—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Nitazoxanide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Nitazoxanide—Diarrhoea—Leflunomide—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Nitazoxanide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Nitazoxanide—Body temperature increased—Lisinopril—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Nitazoxanide—Abdominal pain—Lisinopril—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Nitazoxanide—Pruritus—Mycophenolic acid—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Nitazoxanide—Vomiting—Azathioprine—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Nitazoxanide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Nitazoxanide—Rash—Azathioprine—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Nitazoxanide—Dermatitis—Azathioprine—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Nitazoxanide—Headache—Azathioprine—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Nitazoxanide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Nitazoxanide—Dizziness—Leflunomide—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Nitazoxanide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Nitazoxanide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Nitazoxanide—Pain—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Nitazoxanide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Nitazoxanide—Vomiting—Leflunomide—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Nitazoxanide—Hypersensitivity—Lisinopril—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Nitazoxanide—Dizziness—Mycophenolic acid—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Nitazoxanide—Epistaxis—Methotrexate—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Nitazoxanide—Rash—Leflunomide—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Nitazoxanide—Dermatitis—Leflunomide—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Nitazoxanide—Nausea—Azathioprine—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Nitazoxanide—Headache—Leflunomide—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Nitazoxanide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Nitazoxanide—Asthenia—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Nitazoxanide—Pruritus—Lisinopril—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Nitazoxanide—Vomiting—Mycophenolic acid—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Nitazoxanide—Rash—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Nitazoxanide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Nitazoxanide—Headache—Mycophenolic acid—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Nitazoxanide—Pharyngitis—Methotrexate—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Nitazoxanide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Nitazoxanide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Nitazoxanide—Nausea—Leflunomide—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Nitazoxanide—Diarrhoea—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Prednisone—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Nitazoxanide—Anaemia—Prednisone—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Nitazoxanide—Dizziness—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Nitazoxanide—Nausea—Mycophenolic acid—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Nitazoxanide—Malaise—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Nitazoxanide—Syncope—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Nitazoxanide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Nitazoxanide—Loss of consciousness—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Nitazoxanide—Vomiting—Lisinopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Nitazoxanide—Rash—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Nitazoxanide—Dermatitis—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Nitazoxanide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Nitazoxanide—Hypertension—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Nitazoxanide—Chills—Methotrexate—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Nitazoxanide—Headache—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Nitazoxanide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Nitazoxanide—Myalgia—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Nitazoxanide—Discomfort—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Nitazoxanide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Nitazoxanide—Nausea—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Nitazoxanide—Oedema—Prednisone—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Nitazoxanide—Infection—Prednisone—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Nitazoxanide—Back pain—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Nitazoxanide—Shock—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Nitazoxanide—Tachycardia—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Nitazoxanide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Nitazoxanide—Anorexia—Prednisone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Nitazoxanide—Anaemia—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Nitazoxanide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Nitazoxanide—Rash—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Nitazoxanide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Nitazoxanide—Headache—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Nitazoxanide—Malaise—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Nitazoxanide—Insomnia—Prednisone—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Nitazoxanide—Dyspepsia—Prednisone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Nitazoxanide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Nitazoxanide—Myalgia—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Nitazoxanide—Decreased appetite—Prednisone—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Nitazoxanide—Discomfort—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Nitazoxanide—Constipation—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Nitazoxanide—Infection—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Nitazoxanide—Feeling abnormal—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Nitazoxanide—Anorexia—Methotrexate—systemic scleroderma	0.000983	0.000983	CcSEcCtD
Nitazoxanide—Abdominal pain—Prednisone—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Nitazoxanide—Body temperature increased—Prednisone—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Nitazoxanide—Insomnia—Methotrexate—systemic scleroderma	0.000932	0.000932	CcSEcCtD
Nitazoxanide—Somnolence—Methotrexate—systemic scleroderma	0.000916	0.000916	CcSEcCtD
Nitazoxanide—Hypersensitivity—Prednisone—systemic scleroderma	0.000909	0.000909	CcSEcCtD
Nitazoxanide—Dyspepsia—Methotrexate—systemic scleroderma	0.000907	0.000907	CcSEcCtD
Nitazoxanide—Decreased appetite—Methotrexate—systemic scleroderma	0.000896	0.000896	CcSEcCtD
Nitazoxanide—Asthenia—Prednisone—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Nitazoxanide—Pain—Methotrexate—systemic scleroderma	0.000882	0.000882	CcSEcCtD
Nitazoxanide—Pruritus—Prednisone—systemic scleroderma	0.000873	0.000873	CcSEcCtD
Nitazoxanide—Feeling abnormal—Methotrexate—systemic scleroderma	0.00085	0.00085	CcSEcCtD
Nitazoxanide—Diarrhoea—Prednisone—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000843	0.000843	CcSEcCtD
Nitazoxanide—Dizziness—Prednisone—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Nitazoxanide—Abdominal pain—Methotrexate—systemic scleroderma	0.000815	0.000815	CcSEcCtD
Nitazoxanide—Body temperature increased—Methotrexate—systemic scleroderma	0.000815	0.000815	CcSEcCtD
Nitazoxanide—Vomiting—Prednisone—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Nitazoxanide—Rash—Prednisone—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Nitazoxanide—Dermatitis—Prednisone—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Nitazoxanide—Headache—Prednisone—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Nitazoxanide—Hypersensitivity—Methotrexate—systemic scleroderma	0.00076	0.00076	CcSEcCtD
Nitazoxanide—Asthenia—Methotrexate—systemic scleroderma	0.00074	0.00074	CcSEcCtD
Nitazoxanide—Nausea—Prednisone—systemic scleroderma	0.000733	0.000733	CcSEcCtD
Nitazoxanide—Pruritus—Methotrexate—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Nitazoxanide—Diarrhoea—Methotrexate—systemic scleroderma	0.000705	0.000705	CcSEcCtD
Nitazoxanide—Dizziness—Methotrexate—systemic scleroderma	0.000682	0.000682	CcSEcCtD
Nitazoxanide—Vomiting—Methotrexate—systemic scleroderma	0.000655	0.000655	CcSEcCtD
Nitazoxanide—Rash—Methotrexate—systemic scleroderma	0.00065	0.00065	CcSEcCtD
Nitazoxanide—Dermatitis—Methotrexate—systemic scleroderma	0.000649	0.000649	CcSEcCtD
Nitazoxanide—Headache—Methotrexate—systemic scleroderma	0.000646	0.000646	CcSEcCtD
Nitazoxanide—Nausea—Methotrexate—systemic scleroderma	0.000612	0.000612	CcSEcCtD
